Maurice Zauderer - 18 Sep 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Maurice Zauderer
Issuer symbol: VCNX
Transactions as of: 18 Sep 2024
Net transactions value: +$661,841
Form type: 4
Filing time: 20 Sep 2024, 16:14:02 UTC
Previous filing: 01 Apr 2024
Next filing: 18 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCNX	Common Stock	Options Exercise	$217,606	+38,610	+28%	$5.64	176,748	18 Sep 2024	By Vaccinex (Rochester), L.L.C.	F2, F3
transaction	VCNX	Common Stock	Options Exercise	$166,583	+29,557	+17%	$5.64	206,305	18 Sep 2024	By Vaccinex (Rochester), L.L.C.	F2, F4
transaction	VCNX	Common Stock	Options Exercise	$55,052	+9,768	+4.7%	$5.64	216,073	18 Sep 2024	By Vaccinex (Rochester), L.L.C.	F2, F5
transaction	VCNX	Common Stock	Options Exercise	$201,290	+35,715	+17%	$5.64	251,788	18 Sep 2024	By Vaccinex (Rochester), L.L.C.	F2, F4
holding	VCNX	Common Stock						1,580	18 Sep 2024	Direct
holding	VCNX	Common Stock						1,016	18 Sep 2024	By Jeremy C. Zauderer Trust	F1
holding	VCNX	Common Stock						1,011	18 Sep 2024	By Jordan M. Zauderer Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCNX	Warrant (Right to Buy)	Options Exercise	$0	-38,610	-100%	$0.000000	0	18 Sep 2024	Common Stock	38,610	$5.64	By Vaccinex (Rochester), L.L.C.	F2, F3
transaction	VCNX	Warrant (Right to Buy)	Options Exercise	$0	-29,557	-100%	$0.000000	0	18 Sep 2024	Common Stock	29,557	$5.64	By Vaccinex (Rochester), L.L.C.	F2, F4
transaction	VCNX	Warrant (Right to Buy)	Options Exercise	$0	-9,768	-100%	$0.000000	0	18 Sep 2024	Common Stock	9,768	$5.64	By Vaccinex (Rochester), L.L.C.	F2, F5
transaction	VCNX	Warrant (Right to Buy)	Options Exercise	$0	-35,715	-100%	$0.000000	0	18 Sep 2024	Common Stock	35,715	$5.64	By Vaccinex (Rochester), L.L.C.	F2, F4
transaction	VCNX	Warrant (Right to Buy)	Award	$21,309	+170,475		$0.1250	170,475	18 Sep 2024	Common Stock	170,475	$5.64	By Vaccinex (Rochester), L.L.C.	F2
holding	VCNX	Stock Option (Right to Buy)						12	18 Sep 2024	Common Stock	12	$3129.00	Direct	F6
holding	VCNX	Stock Option (Right to Buy)						12	18 Sep 2024	Common Stock	12	$3129.00	Direct	F6
holding	VCNX	Stock Option (Right to Buy)						15	18 Sep 2024	Common Stock	15	$1491.00	Direct	F6
holding	VCNX	Stock Option (Right to Buy)						135	18 Sep 2024	Common Stock	135	$1402.80	Direct	F6
holding	VCNX	Stock Option (Right to Buy)						66	18 Sep 2024	Common Stock	66	$615.30	Direct	F7
holding	VCNX	Stock Option (Right to Buy)						133	18 Sep 2024	Common Stock	133	$270.90	Direct	F8
holding	VCNX	Stock Option (Right to Buy)						266	18 Sep 2024	Common Stock	266	$92.26	Direct	F9
holding	VCNX	Stock Option (Right to Buy)						1,877	18 Sep 2024	Common Stock	1,877	$8.21	Direct	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
F2	Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3	This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the "Warrant Inducement Agreement"), the exercise price of this warrant was adjusted to $5.636.
F4	This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636.
F5	This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636.
F6	Exercisable in full as of the date of this report.
F7	This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
F8	This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
F9	This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
F10	This option vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date, except as otherwise provided in the award notice.